Vudalimab Biosimilar - Research Grade

Vudalimab Biosimilar - Research Grade, Human IgG1 (N208D/E233P/L234V/L235A/G236Del/S267K/Q295E/L368D/K370S/N384D/Q418E/N421D/M428L/N434S)-Kappa

Target: PD-1 + CTLA-4

Specificity: Detects human PD-1 and human CTLA-4

Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Background: Uses the same sequence as the therapeutic antibody Vudalimab

Concentration: 5mg/ml

Formulation: 20mM His/Asp, pH 5.0,Contains no stabilizers or preservatives

Purity: >90% by SDS-PAGE

Endotoxin: <1EU/mg Determined by LAL gel clotting assay

Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.

• SKU: ICH5113-50mg
• Manufacturer: Ichorbio
• Manufacturer SKU: ICH5113-50mg
• Package Unit: 50mg
• Quantity Unit: STK
• Reactivity: Human
• Clonality: Monoclonal
• Application: Functional Assay
• Isotype: Human IgG1 (N208D/E233P/L234V/L235A/G236Del/S267K/Q295E/L368D/K370S/N384D/Q418E/N421D/M428L/N434S)-Kappa